首页> 外文会议>International symposium on controlled release of bioactive materials;Consumer and diversified products conference >Controlled Release of Methotrexate from the Porous Poly(l-lactide) Matrix for the Treatment of Osteosarcoma
【24h】

Controlled Release of Methotrexate from the Porous Poly(l-lactide) Matrix for the Treatment of Osteosarcoma

机译:甲氨蝶呤从多孔聚(l-丙交酯)基质中的控制释放,以治疗骨肉瘤。

获取原文

摘要

Among a variety of biodegradable polymers, poly(lactide) has been widely used as polymeric materials for the preparation of drug delivery device. To modify the release behavior of drugs from the poly(lactide) polymers, trials such as co-polymerization of lactide and other co-monomers or blending with other biocompatible polymers have been reported. Examples of blending with other polymers were performed with biodegradable or non-biodegradable polymers such as poly(glycolide), poly(ethylene-co-vinyl acetate), and PEO/PPO/PEO triblock copolymers. Bledning of poly(lactide) with other polymers usually gives different drug release rate owing to the different morphology and matrix characteristics.
机译:在各种可生物降解的聚合物中,聚丙交酯已被广泛用作制备药物递送装置的聚合物材料。为了改变药物从聚丙交酯聚合物中的释放行为,已经报道了诸如丙交酯和其他共聚单体的共聚或与其他生物相容性聚合物共混的试验。与其他聚合物共混的例子是用可生物降解或不可生物降解的聚合物(例如聚(乙交酯),聚(乙烯-乙酸乙烯酯)和PEO / PPO / PEO三嵌段共聚物)进行的。由于不同的形态和基质特性,聚丙交酯与其他聚合物的混炼通常会产生不同的药物释放速率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号